In a Chinese opportunistic screening study, a different SEPT9 gene methylation assay called SensiColon was validated, showing 76.6% specificity and 95.9% sensitivity for the detection of early CRC stages [78]. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.